Skip to main content

Advertisement

Figure 3 | BMC Cancer

Figure 3

From: A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis

Figure 3

Limited tumor implantation. Injection of cell suspension under the capsule of the peritoneal surface preventing diffuse peritoneal carcinomatosis (a). Isolated tumour nodule without diffuse carcinoses 10 days after implantation (b). Representative gross sections of peritoneal carcinomatosis in group I (control), II (HIPEC) and group III (MMC only) 10 days postoperatively.

Back to article page